相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanoparticle Engineering of Aprepitant Using Nano-by-Design (NbD) Approach
Pratik Kakade et al.
AAPS PHARMSCITECH (2022)
NK1 receptor antagonists versus other antiemetics in the prevention of postoperative nausea and vomiting following laparoscopic surgical procedures: a systematic review and meta-analysis
John Cavaye et al.
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY (2022)
Cost-Effectiveness of Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Published Articles
Tingting Qiu et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Effect of combinations of dexamethasone-ondansetron and dexamethasone-ondansetron-aprepitant versus aprepitant alone for early postoperative nausea and vomiting after day care gynaecological laparoscopy: A randomised clinical trial
Ingilala L. Thanuja et al.
INDIAN JOURNAL OF ANAESTHESIA (2021)
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: an abridged Cochrane network meta-analysis
S. Weibel et al.
ANAESTHESIA (2021)
Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting
Tong J. Gan et al.
ANESTHESIA AND ANALGESIA (2020)
Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis
Chiaki Murakami et al.
REVISTA BRASILEIRA DE ANESTESIOLOGIA (2020)
A Comprehensive Approach for the Prevention of Nausea and Vomiting Following Sleeve Gastrectomy: a Randomized Controlled Trial
Konstantinos Spaniolas et al.
OBESITY SURGERY (2020)
Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial
Thiago Ramos Grigio et al.
CLINICS (2020)
Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects
F. Tansu Salman et al.
JOURNAL OF PEDIATRIC SURGERY (2019)
Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults
Meinolf Karthaus et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Comparing the efficacy of aprepitant and ondansetron for the prevention of postoperative nausea and vomiting (PONV): A double blinded, randomised control trial in patients undergoing breast and thyroid surgeries
Salome Jeyabalan et al.
INDIAN JOURNAL OF ANAESTHESIA (2019)
Aprepitant as a fourth antiemetic prophylactic strategy in high-risk patients: a double-blind, randomized trial
L. C. de Morais et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2018)
Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2)
Aaron B. Caughey et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Effect of the Dexamethasone-Ondansetron Combination Versus Dexamethasone-Aprepitant Combination to Prevent Postoperative Nausea and Vomiting
Sevgi Bilgen et al.
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION (2018)
Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia
Jae Hwa Yoo et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2018)
Fosaprepitant versus droperidol for prevention of PONV in craniotomy: a randomized double-blind study
Jun Atsuta et al.
JOURNAL OF ANESTHESIA (2017)
In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations
Carl Roos et al.
MOLECULAR PHARMACEUTICS (2017)
Aprepitant for postoperative nausea and vomiting: a systematic review and meta-analysis
Preet Mohinder Singh et al.
POSTGRADUATE MEDICAL JOURNAL (2016)
Aprepitant for antiemesis after laparoscopic gynaecological surgery A randomised controlled trial
Sung Yeon Ham et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2016)
Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonosetron Versus Aprepitant Plus Ramosetron in Patients at High Risk for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized-controlled Trial
Eun Kyung Choi et al.
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES (2016)
The effects of intravenous fosaprepitant and ondansetron in the prevention of postoperative nausea and vomiting in patients who underwent lower limb surgery: a prospective, randomized, double-blind study
Nami Kakuta et al.
JOURNAL OF ANESTHESIA (2015)
Fosaprepitant versus ondansetron for the prevention of postoperative nausea and vomiting in patients who undergo gynecologic abdominal surgery with patient-controlled epidural analgesia: a prospective, randomized, double-blind study
Tomohiro Soga et al.
JOURNAL OF ANESTHESIA (2015)
Neurokinin-1 Receptor Antagonists in Preventing Postoperative Nausea and Vomiting A Systematic Review and Meta-Analysis
Meng Liu et al.
MEDICINE (2015)
Aprepitant's Prophylactic Efficacy in Decreasing Postoperative Nausea and Vomiting in Morbidly Obese Patients Undergoing Bariatric Surgery
Ashish C. Sinha et al.
OBESITY SURGERY (2014)
Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial
Hyoung Yong Moon et al.
BMC ANESTHESIOLOGY (2014)
The Effects of Intravenous Fosaprepitant and Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Neurosurgery Patients: A Prospective, Randomized, Double-Blinded Study
Yasuo M. Tsutsumi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Oral administration of aprepitant to prevent postoperative nausea in highly susceptible patients after gynecological laparoscopy
Wol Seon Jung et al.
JOURNAL OF ANESTHESIA (2013)
Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting
Chae Seong Lim et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2013)
Postoperative Nausea and Vomiting Prophylaxis From an Economic Point of View
Roger Dzwonczyk et al.
AMERICAN JOURNAL OF THERAPEUTICS (2012)
Randomized, double-blind comparison of oral aprepitant alone compared with aprepitant and transdermal scopolamine for prevention of postoperative nausea and vomiting
M. S. Green et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Aprepitant plus Ondansetron Compared with Ondansetron Alone in Reducing Postoperative Nausea and Vomiting in Ambulatory Patients Undergoing Plastic Surgery
Manuel C. Vallejo et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2012)
The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone
Se-Jin Lee et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2012)
A Comparison of the Combination of Aprepitant and Dexamethasone Versus the Combination of Ondansetron and Dexamethasone for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy
Ashraf S. Habib et al.
ANESTHESIA AND ANALGESIA (2011)
Neurokinin-1 receptor antagonism, aprepitant, effectively diminishes post-operative nausea and vomiting while increasing analgesic tolerance in laparoscopic gynecological procedures
Nami Kakuta et al.
JOURNAL OF MEDICAL INVESTIGATION (2011)
Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting
P. Diemunsch et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Aprepitant A Review of its Use in the Prevention of Nausea and Vomiting
Monique P. Curran et al.
DRUGS (2009)
Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant
Pierre Diernunsch et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting:: a randomized, double-blind Phase III trial in patients undergoing open abdominal surgery
P. Diemunsch et al.
BRITISH JOURNAL OF ANAESTHESIA (2007)
A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting
Tong J. Gan et al.
ANESTHESIA AND ANALGESIA (2007)
Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis
Ashraf S. Habib et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers
AK Majumdar et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Effect of impaired renal function and haemodialysis on the pharmacokinetics of aprepitant
AJ Bergman et al.
CLINICAL PHARMACOKINETICS (2005)
Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant
RI Sanchez et al.
DRUG METABOLISM AND DISPOSITION (2004)
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant
M Bergström et al.
BIOLOGICAL PSYCHIATRY (2004)
Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting
LHJ Eberhart et al.
ANAESTHESIA (2002)
Central neurocircuitry associated with emesis
PJ Hornby
AMERICAN JOURNAL OF MEDICINE (2001)
Substance P (neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures
Z Gesztesi et al.
ANESTHESIOLOGY (2000)
Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo
RP Hill et al.
ANESTHESIOLOGY (2000)
Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10 811 patients
PS Myles et al.
BRITISH JOURNAL OF ANAESTHESIA (2000)
分享论文
